VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.90 Cr | ₹10 Cr | ₹8.85 Cr | ₹7.95 Cr | ₹7.38 Cr |
What is the latest Long Term Provisions ratio of VENUS REMEDIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹2.90 Cr |
| Mar2024 | ₹10 Cr |
| Mar2023 | ₹8.85 Cr |
| Mar2022 | ₹7.95 Cr |
| Mar2021 | ₹7.38 Cr |
How is Long Term Provisions of VENUS REMEDIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.90 Cr | -71.74 | |
| Mar2024 | ₹10 Cr | 15.96 | |
| Mar2023 | ₹8.85 Cr | 11.21 | |
| Mar2022 | ₹7.95 Cr | 7.84 | |
| Mar2021 | ₹7.38 Cr | - | |
Compare Long Term Provisions of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,223.5 Cr | -6.4% | -14.4% | 200.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -6.4% |
-14.4% |
200.9% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses